PDIA3 and breast carcinoma: Studies have shown that PDIA3 expression is related to the prognosis of ovarian cancer [24], gastric cancer [25], renal cancer, laryngeal cancer [26], breast cancer, cervical cancer, lung cancer [27], and prostate cancer.